Hualan Biological Engineering Inc.: Planning to acquire Lai Shi Medical through stock swap, stock trading halted

Jinshi data, December 22 news, Haier Biology announced that the company is planning to absorb and merge Shanghai Laisi by issuing A shares to all shareholders of Shanghai Laisi, and issuing A shares to raise supporting funds. As this transaction is still in the planning stage and there is uncertainty, in order to ensure fair information disclosure and protect the interests of investors, the company's securities are scheduled to be suspended from December 23, 2024, and the suspension period is expected to be no more than 10 trading days.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)